Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 30, 2026

Conditions

Liver FibrosesHBV (Hepatitis B Virus)

Interventions

DRUG

Entecavir (ETV)

"Standard antiviral therapy with Entecavir 0.5 mg orally once daily for 6 months.(control group)"

DRUG

Zinc (zinc sulphate)

"Zinc sulfate 220 mg orally once daily (50 mg elemental zinc) in addition to Entecavir 0.5 mg, for 6 months."

All Listed Sponsors

lead

Tanta University

OTHER